![](https://investorshub.advfn.com/uicon/316655.png?cb=1525205918)
Friday, March 05, 2021 11:32:44 AM
On March 3, 2021, the Board of Directors of AngioSoma, Inc. (the “Company”) appointed James C. Katzaroff Director, President and Chief Executive Officer of the corporation.
On March 3, 2021, the Board of Directors of the Company accepted Alex K. Blankenship’s resignation from all positions with the Company. Ms. Blankenship also transferred voting control to James C. Katzaroff.
James C. Katzaroff successfully negotiated with the holder of a patented treatment for Multiple Sclerosis for an exclusive perpetual license. Mr. Katzaroff is the founder of Advanced Medical Isotope Corp. (now known as Radiogel) and was the Chairman and Chief Executive Officer from 2007 through December 2016. Since December 2016 to present, Mr. Katzaroff is Senior Managing Director at KATMO, LLC.
Hummmm they are located in Huston !!! This could be HUGE !!! IMO !!!
Weeeeeeee !!! $$ PVDG $$
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM